SCHEMBL16403937

SCHEMBL16403937

Cc1nc(-c2cc(C(=O)N3CCCC3c3ccc4c(c3)OCCO4)n(C)c2)cs1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.47
▸ RAB9A P51151 4/20 0.47
▸ SMN1; SMN2 Q16637 4/20 0.47
▸ ALDH1A1 P00352 3/20 0.47
▸ SCD5 Q86SK9 9/20 0.42
▸ ROCK2 O75116 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.40
▸ SCD O00767 2/20 0.40
▸ ERBB2 P04626 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ NFKB1 P19838 1/20 0.39
▸ NFKB2 Q00653 1/20 0.39
▸ RELA Q04206 1/20 0.39
▸ HCRTR1 O43613 1/20 0.39
▸ HCRTR2 O43614 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16403930 0.97 NPC1 (0.49) NPC1RAB9ASMN1; SMN2ALDH1A1SCD5
SCHEMBL16404125 0.84 SCD (0.47) SMN1; SMN2ALDH1A1ROCK2SCDMAPT
SCHEMBL16403957 0.83 HSD17B10 (0.52) NPC1RAB9ASCD5ROCK2HSD17B10
SCHEMBL16403960 0.83 SCD (0.42) SMN1; SMN2SCD5ROCK2HSD17B10SCD
SCHEMBL16403934 0.76 TRPV1 (0.40) NPC1RAB9AALDH1A1SCD5ROCK2
SCHEMBL16403958 0.76 HCRTR1 (0.48) SCD5ROCK2SCDHCRTR1HCRTR2
SCHEMBL16404086 0.76 SCD (0.42) SMN1; SMN2SCD5HSD17B10SCDHCRTR1
SCHEMBL16403918 0.71 NPC1 (0.47) NPC1RAB9ASMN1; SMN2ALDH1A1ROCK2
SCHEMBL16403992 0.71 RAB9A (0.60) NPC1RAB9ASMN1; SMN2ALDH1A1POLB
SCHEMBL16403916 0.71 ALDH1A1 (0.48) NPC1RAB9ASMN1; SMN2ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8937065-B2 Compositions and methods for modulating a kinase CLEVEXEL PHARMA (FR) 2015-01-20 — — US disclosed
US-8937065-B2 Compositions and methods for modulating a kinase CLEVEXEL PHARMA (FR) 2015-01-20 — — US disclosed
Send feedback